To our knowledge, the data on the hematological neoplasms are scarce, and no other data on WM, evaluating CCL2 and CCL4 as chemoattractant cytokines for TAM recruitment, along with CD163. This evidence concerns the gene CCL2 and hematopoietic and lymphoid system neoplasm.